SCHEMBL8375411

SCHEMBL8375411

CCN(CC)c1nc(Cl)c2cc(Cl)ccc2n1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.47
KDM4E B2RXH2 3/20 0.43
MAPK1 P28482 1/20 0.43
HTR2C P28335 2/20 0.39
HTR2A P28223 1/20 0.39
CTNNB1 P35222 1/20 0.39
TCF7L2 Q9NQB0 1/20 0.39
ALDH1A1 P00352 3/20 0.39
FABP4 P15090 2/20 0.39
FABP5 Q01469 2/20 0.39
POLB P06746 2/20 0.38
GAA P10253 1/20 0.38
TSHR P16473 1/20 0.38
ADORA3 P0DMS8 1/20 0.37
FABP3 P05413 1/20 0.37
EGFR P00533 1/20 0.37
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8660014 0.80 ADORA3 (0.51) RXFP1KDM4EALDH1A1GAAADORA3
SCHEMBL4413557 0.75 KDM4E (0.48) KDM4EMAPK1ALDH1A1FABP4FABP5
SCHEMBL8381530 0.74 ACP1 (0.42) KDM4EMAPK1ALDH1A1FABP4FABP5
SCHEMBL26534113 0.73 NPY5R (0.47) KDM4EMAPK1ALDH1A1
SCHEMBL4417128 0.72 KDM4E (0.49) KDM4EMAPK1ALDH1A1FABP4POLB
SCHEMBL10730888 0.72 CSF1R (0.43) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL405341 0.71 KDM4E (0.44) KDM4EMAPK1ALDH1A1GAAMAPT
SCHEMBL30013869 0.71 KDM4E (0.44) KDM4EMAPK1ALDH1A1GAAMAPT
SCHEMBL9266044 0.69 KDM4E (0.44) KDM4EMAPK1ALDH1A1MAPTKMT2A
SCHEMBL3668583 0.69 KDM4E (0.48) KDM4EMAPK1ALDH1A1ADORA3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5874438-A A DRUG TREATING BRAIN DISORDERS, DISEASES OF CENTRAL NERVOUS SYSTEM, DEMENTIA, DEPRESSION, MYOTONIC DYSTROPHY, ASTHMA BAYER AKTIENGESELLSCHAFT (DE) 1999-02-23 US disclosed